Sickle cell patients and campaign groups have called a decision not to approve a new type of gene therapy for NHS use a 'shocking letdown'.
Sickle cell patients and campaign groups have called a decision not to approve a new type of gene therapy for NHS use a “shocking letdown”.
There are more than 17,000 people living with sickle cell disease in the UK, and the medicine watchdog’s approval of the new treatment in November was widely welcomed. It works by editing faulty genes to help the body produce functioning haemoglobin. But the National Institute for Health and Care Excellence said today there is not enough data for the NHS to fund it.
We’re joined by Yasmin Sheikh from the Anthony Nolan stem cell charity, and Iggie Aikhomu, who had a stem cell transplant for the disease.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Annual indirect economic burden of sickle cell disease over $2 millionAdults with sickle cell disease (SCD) are more likely to report employment loss, and caregivers of children with SCD report more missed days of work, according to a study published online Feb. 29 in Blood Advances.
続きを読む »
Prestwick man, 54, in 'unbelievable' pain stuck in NHS limbo over surgery delaysRobert McGinnis, who turns 55 this month, claims he’s in agonising daily pain with a broken back, a knee which needs replaced and a hernia issue which also requires surgery.
続きを読む »
'Superior' awards for bosses in struggling NHS boardsMany NHS executives across Scotland are being given top appraisal marks which are linked to pay rises.
続きを読む »
Portakabin hospital ward delayed over safety fearsVentilation and fire safety improvements are needed on the NHS Forth Valley project say trouble-shooters.
続きを読む »
FactCheck: 12-week waits for inpatient care in Scotland 125 times higher than a decade agoThe picture across Scotland's NHS is stark.
続きを読む »
UK finance minister promises NHS £3.4B IT investment to unlock £35B savingsNow, who was it 'challenged' the NHS to go paperless by 2018?
続きを読む »